Literature DB >> 19338153

[Effect of aike mixture on fibroplasia and inflammatory infiltration in rats with non-bacterial prostatitis].

Min-jian Zhang1, Ke-dan Chu, Xin-ling Cheng.   

Abstract

OBJECTIVE: To assess the anti-inflammatory effect of Aike Mixture (AKM) on rats with nonbacterial prostatitis (NBP).
METHODS: Rat model of NBP was established by injection of Xiaozhiling Injection. The experimental rats were randomized into 7 groups: the three AKM groups (A1, A2 and A3), treated with high, middle and low dose of AKM respectively, the 2 positive control groups (C1 and C2), treated by Bazheng Mixture (BZM) and Qianliexian Decoction (QLXD) respectively, the model control group (Cm) and the sham-operative control group (Cso). The pathological changes in rats' prostate were observed by light microscope and transmission electron microscope.
RESULTS: Significant differences in the number and structure of acini, mesenchyma, as well as the degrees of anti-fibroplasia and inflammatory cell infiltration were shown between the treated groups (A1, A2, A3, C1, C1, C2) and the untreated groups (Cm, Cso), with statistical significance (P < 0.05 or P < 0.01). However, the anti-fibroplasia and anti-inflammatory effects in A1 were better than that in the two positive control groups significantly (P < 0.05 or P < 0.01).
CONCLUSIONS: AKM is a new TCM drug functioned for dispersing Gan-qi in treating NBP. It shows a better efficacy than that of BZM and QLXD, the two Chinese herbal medicines for clearing heat with remove dampness and activating blood circulation to remove stasis, respectively. Aike Mixture; prostatitis; pathological observation

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19338153

Source DB:  PubMed          Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi        ISSN: 1003-5370


  1 in total

1.  Relaxant effects of Aike Mixture on isolated bladder and prostatic urethral smooth muscle of rabbits.

Authors:  Min-jian Zhang; Ya-lei Shi; Wan-jun Cheng; Zhen-wei Li; Xiang Lin
Journal:  Chin J Integr Med       Date:  2012-05-19       Impact factor: 1.978

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.